Samsung Becomes Largest Shareholder in US Genomics Firm Element Biosciences
Samsung Electronics has invested $175 million in Element Biosciences' Series E funding round, making it the largest shareholder in the US genomics firm. This strategic investment positions Samsung as a key player in the biotech sector.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)Sources
Samsung becomes largest shareholder of US genomics firm Element
Samsung Electronics said Wednesday it has invested an additional $175 million in US biotechnology company Element Biosciences, becoming the firm's largest shareholder as it seeks to expand into precision medicine and next-generation healthcare technologies. The investment was made through Element's Series E funding round, following Samsung's participation in the company's Series D financing in July 2024. Samsung said the latest investment will strengthen its position in the rapidly growing preci
By The Korea Herald
Read full article →
